SLU‑PP‑332 is a small‑molecule agonist of the estrogen‑related receptors (ERRα, ERRβ, and ERRγ) with potent metabolic‑enhancing properties. By activating these nuclear receptors, SLU‑PP‑332 promotes mitochondrial biogenesis, increases energy expenditure, and enhances fatty acid oxidation. It is primarily used in research to explore pathways related to fat metabolism, endurance, and improved metabolic efficiency.